SEC Filing Summary for James N. Wilson

This filing details transactions related to Corcept Therapeutics Inc. Common Stock by James N. Wilson. On March 13, 2026, Mr. Wilson, a director, disposed of 28,000 shares through a gift transaction with no associated price. Following this transaction, his reported holdings include 901,067 shares held indirectly through the James and Pamela Wilson Family Partners, 200,000 shares through the James N. Wilson 2025 Grantor Retained Annuity Trust, and 200,000 shares through the Pamela D. Wilson 2025 Grantor Retained Annuity Trust. Mr. Wilson has voting power over shares held by the James N. Wilson and Pamela D. Wilson Trust and the James and Pamela Wilson Family Partners, disclaiming beneficial ownership except for his pecuniary interest.